Anuh Pharma
add_icon

Anuh Pharma

76.67
+0.20
(0.26%)
Market Cap
768.42 Cr
PE Ratio
18.68
Volume
18,611.00
Day High - Low
76.99 - 76.20
52W High-Low
114.90 - 67.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
768.42 Cr
EPS
4.10
PE Ratio
18.68
PB Ratio
2.18
Book Value
35.14
EBITDA
61.72
Dividend Yield
1.96 %
Industry
Healthcare
Return on Equity
14.52
Debt to Equity
0.02
Forecast For
Actual

Company News

View All News
Caret
positive
Anuh Pharma reported a net profit of ₹4,104.61 lakh for FY26, with revenue rising to ₹77,165.74 lakh. The board recommended a dividend of ₹1.50 per share.
neutral
Nine shareholders holding 0.95% of Anuh Pharma seek reclassification from promoter group to public category. The board will consider the requests under SEBI LODR regulations.
positive
Anuh Pharma Limited received WHO Prequalification approval for Amodiaquine Hydrochloride USP, an anti-malarial API. This approval enables participation in global procurement initiatives.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,844.30
#1 4,42,509.35
38.37
#1 58,220.10
6.38
#1 11,565
25.80
54.66
6,797.50
1,80,452.27
69.82
10,560.00
8.73
2,520
13.44
59.28
4,537.80
1,53,579.77
70.46
13,753.00
19.18
2,028
-26.91
60.91
1,418.20
1,14,559.46
29.64
27,711.70
-2.46
3,783
-55.32
64.86
1,319.00
1,10,089.41
26.69
33,593.30
-0.44
3,998
-86.05
54.22
1,085.80
1,09,256.89
21.19
26,719.70
13.65
5,242
7.82
75.42
2,276.40
1,04,041.32
#1 19.33
27,487.50
19.98
5,345
#1 87.72
46.91
2,420.40
99,915.34
51.52
14,277.60
12.03
1,750
31.75
55.29
1,435.90
83,397.31
24.27
33,384.70
3.21
3,376
1.99
47.24
1,381.70
74,591.98
83.31
6,812.90
#1 21.03
884
21.18
80.70
Growth Rate
Revenue Growth
15.00 %
Net Income Growth
-17.30 %
Cash Flow Change
187.08 %
ROE
-29.58 %
ROCE
-30.06 %
EBITDA Margin (Avg.)
-24.21 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Revenue
289
330
214
246
325
311
443
492
534
659
671
772
Expenses
254
290
184
220
291
284
387
440
476
572
601
710
EBITDA
35
40
30
25
34
27
55
52
57
87
70
62
Operating Profit %
11 %
11 %
11 %
8 %
9 %
7 %
10 %
10 %
10 %
12 %
9 %
8 %
Depreciation
3
2
2
2
2
7
15
12
10
9
9
11
Interest
0
0
0
0
0
1
2
1
0
0
1
0
Profit Before Tax
32
38
28
23
32
19
39
39
48
78
61
54
Tax
10
12
8
7
9
5
10
9
11
18
14
15
Net Profit
22
26
20
17
23
14
28
31
36
60
47
39
EPS in ₹
8.78
10.30
8.00
6.59
9.33
2.85
5.67
6.10
7.22
11.98
9.45
4.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
168
193
189
209
240
326
333
347
405
446
507
557
Fixed Assets
10
18
17
17
21
84
71
61
53
49
58
57
Current Assets
144
151
138
154
152
223
238
259
308
339
376
451
Capital Work in Progress
0
0
0
6
34
0
0
0
0
1
0
0
Investments
29
22
70
66
39
80
31
43
91
97
106
148
Other Assets
129
152
101
120
147
163
230
243
261
300
342
0
Total Equity & Liabilities
168
193
189
209
240
326
333
347
405
446
507
557
Current Liabilities
67
73
47
59
75
163
140
131
161
153
179
203
Non Current Liabilities
1
1
1
1
1
2
3
3
2
2
2
2
Total Equity
101
119
141
150
165
162
191
214
241
291
326
352
Reserve & Surplus
97
107
128
137
152
150
166
189
216
266
301
302
Share Capital
4
13
13
13
13
13
25
25
25
25
25
50

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-1
2
2
-1
4
-5
0
2
-2
5
12
Investing Activities
-12
-5
-20
2
3
-77
52
-8
-44
1
-20
Operating Activities
19
17
26
2
7
49
-19
29
54
13
37
Financing Activities
-8
-9
-4
-5
-7
22
-33
-20
-12
-9
-5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
70.47 %
70.43 %
70.43 %
70.45 %
70.44 %
70.59 %
70.59 %
70.59 %
70.59 %
70.59 %
70.59 %
69.94 %
69.92 %
69.92 %
69.92 %
69.92 %
69.92 %
69.92 %
69.92 %
71.82 %
71.82 %
71.80 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.03 %
0.03 %
0.02 %
0.02 %
0.04 %
0.04 %
0.03 %
0.00 %
0.00 %
0.05 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.11 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.04 %
26.27 %
26.33 %
26.26 %
26.16 %
26.18 %
26.12 %
26.00 %
25.94 %
25.68 %
25.79 %
26.14 %
26.20 %
26.30 %
26.27 %
26.02 %
25.92 %
25.89 %
25.83 %
23.86 %
23.74 %
23.57 %
Others
3.49 %
3.30 %
3.25 %
3.29 %
3.41 %
3.23 %
3.28 %
3.41 %
3.47 %
3.73 %
3.61 %
3.92 %
3.75 %
3.75 %
3.79 %
4.04 %
4.13 %
4.16 %
4.23 %
4.33 %
4.44 %
4.59 %
No of Share Holders
19,442
22,457
22,779
21,500
21,123
20,740
20,452
20,470
19,969
19,423
19,066
20,519
22,237
23,494
23,910
24,048
24,235
24,257
26,157
28,250
27,889
27,425

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.5 1.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.35 2.24 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
12 Aug 2026 79.96 76.47
21 Sept 2020 BONUS Bonus
1:1
18 Sept 2020 90.73 103.15
19 Aug 2021 DIVIDEND Dividend
₹ 1.50 /share
17 Aug 2021 75.38 60.50
05 Aug 2022 DIVIDEND Dividend
₹ 1.75 /share
03 Aug 2022 46.15 50.50
11 Aug 2023 DIVIDEND Dividend
₹ 2.00 /share
11 Aug 2023 46.97 66.08
16 Aug 2024 DIVIDEND Dividend
₹ 2.50 /share
16 Aug 2024 120.33 103.55
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 120.33 105.05
08 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Nov 2024 95.45 100.33
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 97.33 102.43
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 90.35 106.08
15 Jul 2025 BONUS Bonus
1:1
15 Jul 2025 110.41 103.88
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 97.90 90.45
15 Aug 2025 DIVIDEND Dividend
₹ 1.50 /share
14 Aug 2025 106.08 88.30
22 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
22 Aug 2025 106.08 92.05
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 89.56 86.17
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2026 74.00 79.81
20 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2026 78.98 79.96

Announcements

Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20151 day ago
Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20154 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication5 days ago
Announcement Under Regulation 30 (LODR) - Adoption For Policy For Implementation Of NFRA Circular6 days ago
Announcement Under Regulation 30 (LODR) - Appointment Of Scrutinizer For The 66Th Annual General Meeting.6 days ago
Announcement Under Regulation 30 (LODR) - 66Th Annual General Meeting Will Be Held On Wednesday 12Th August 2026.6 days ago
Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 20156 days ago
Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination Of Materiality Of Events.6 days ago
Announcement Under Regulation 30 (LODR) - Adoption Of Memorandum Of Association (MOA) And Articles Of Association (AOA) As Per Companies Act 20136 days ago
Announcement Under Regulation 30 (LODR) - Re-Appointment Of Cost Auditor6 days ago
Announcement Under Regulation 30 (LODR) - Appointment Of Internal Auditor.6 days ago
Announcement Under Regulation 30 (LODR) - Appointment Of Mr. P.N. Rao As General Manager - Quality6 days ago
Announcement under Regulation 30 (LODR)-Change in Management6 days ago
Corporate Action - Fixes Record Date For Dividend6 days ago
Corporate Action-Board approves Dividend6 days ago
Results - Financials Results For The Year Ended 31/03/20266 days ago
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 20/05/20266 days ago
Intimation Of Requests Received For Reclassification By Promoter Group To Public Under Regulation 31A Of SEBI (LODR) Regulations 2015.8 days ago
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Financial Year Ended 31St March 2026 Recommendation Of Final Dividend If Any And Consideration Of AGM Notice For The Financial Year 2025-26.May 15, 2026
Announcement Under Regulation 30 (LODR) - UpdatesMay 04, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 28, 2026
Announcement Under Regulation 30 (LODR)-Newspaper PublicationApr 17, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Closure of Trading WindowMar 27, 2026
Announcement Under Regulation 30 (LODR) - Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) Audit And Our Facilities Were Found Compliant Under The Audit.Mar 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 18, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2026
Announcement Under Regulation 30 (LODR) - Completion Of United States Food And Drug Administration (USFDA) Inspection With No Form 483 Observations IssuedFeb 06, 2026
Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination Of Materiality Of Events.Feb 06, 2026
Results-Financial Results For December 31 2025Feb 06, 2026
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 06/02/2026Feb 06, 2026
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 31St December 2025.Feb 02, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR)Jan 21, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Announcement Under Regulation 30 (LODR) - UpdatesDec 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 09, 2025
Announcement Under Regulation 30 (LODR) - Adoption Of Revised Polices And CodesNov 07, 2025
Results-Financial Results For September 30 2025Nov 07, 2025
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 07/11/2025Nov 07, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025.Oct 31, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Closure of Trading WindowSep 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 26, 2025
Announcement under Regulation 30 (LODR)-Credit RatingSep 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 26, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.02%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
42.66
ATR(14)
Less Volatile
2.98
STOCH(9,6)
Neutral
23.38
STOCH RSI(14)
Oversold
8.13
MACD(12,26)
Bearish
-0.73
ADX(14)
Weak Trend
17.34
UO(9)
Bearish
35.40
ROC(12)
Downtrend And Accelerating
-8.59
WillR(14)
Oversold
-85.08